←Back to Expert Scholars
Translational Medicine / 转化医学Oligometastatic Disease
Piet Ost
MD, PhD
🏢Iridium Netwerk, University of Ghent🌐Belgium
Professor of Radiation Oncology
60
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Piet Ost led the STOMP trial of metastasis-directed therapy in hormone-sensitive oligometastatic prostate cancer, one of the first randomized studies to show benefit. He is a European leader in oligometastatic prostate cancer research. His work integrates PSMA PET imaging with metastasis-directed therapy.
Share:
🧪Research Fields 研究领域
prostate oligometastases
metastasis-directed therapy
STOMP trial
PSMA imaging
hormone-naive prostate cancer
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Piet Ost 的研究动态
Follow Piet Ost's research updates
留下邮箱，当我们发布与 Piet Ost（Iridium Netwerk, University of Ghent）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment